Cipla promoters sell 2.53% stake in company for Rs 2,637 cr
Mumbai: The promoters of Cipla have sold a 2.53% stake in the company for 'creating liquidity' for specific needs including 'philanthropy', the Mumbai headquartered pharma major said on Wednesday.
Shirin Hamied, Rumana Hamied, Samina Hamied, and Okasa Pharma Private Limited (categorised as a promoter group) have sold 2.53 percent shares of Cipla, the company said in a stock market filing.
"Post transaction, the entire promoter group (including Person Acting in Concert) continues to hold 31.67 percent in the company and remains committed to the future of Cipla Limited," it added.
The promoters owned 33.47 percent of the company's shares in total as of the end of March.
This comes eight months after the talks for promoter stake sales with Torrent Pharmaceuticals failed.
Okasa Pharma, which belongs to another promoter group, along with MK Hamied's wife Shirin and their daughters Samina and Rumana, together divested a stake of around 2.53 percent, fetching an estimated Rs 2,637 crore, reported Business Standard.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
